drospirenone and ethinyl estradiol combination has been researched along with Recrudescence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, M; Greenberg, JA; Ward, HB | 1 |
| Fait, T; Jarosová, R | 1 |
| Basaran, O; Candan, O; Esen, AM; Guler, A; Izgi, A; Kalayci, A; Karabay, CY; Karagöz, A; Kırma, C; Kocabay, G; Oduncu, V; Zehir, R | 1 |
1 review(s) available for drospirenone and ethinyl estradiol combination and Recrudescence
| Article | Year |
|---|---|
Perimenstrual psychiatric hospitalization: case report and literature review.
Topics: Adult; Androstenes; Antipsychotic Agents; Catatonia; Ethinyl Estradiol; Female; Hospitalization; Humans; Menstrual Cycle; Premenstrual Syndrome; Psychotic Disorders; Recurrence; Reproductive Control Agents; Treatment Outcome | 2020 |
2 other study(ies) available for drospirenone and ethinyl estradiol combination and Recrudescence
| Article | Year |
|---|---|
[Combined hormonal contraception in woman with persistent functional ovarian cysts--case report].
Topics: Adult; Androstenes; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hysterectomy; Ovarian Cysts; Recurrence | 2009 |
Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.
Topics: Adult; Age Factors; Aged; Androstenes; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Comorbidity; Contraceptives, Oral; Coronary Angiography; Coronary Thrombosis; Ethinyl Estradiol; Female; Heart Failure; Hospital Mortality; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Smoking; Treatment Outcome; Turkey | 2013 |